BACKGROUND: P-glycoprotein (P-gp), the product of the multidrug resistance gene (MDR), is an ATP-dependent transmembrane pump, which is expressed in multiple cell lineages including epithelial and hematopoetic cells. The human MDR gene is located on chromosome 7 (7q21.1), a susceptibility loci for inflammatory bowel disease (IBD). A significant number of IBD patients carry mutations in this gene and P-gp-deficient FVB/N mice develop a severe spontaneous colitis, characterized by impaired intestinal barrier function and immune reactivity to intestinal bacterial antigens. METHODS: In this work we explored the role of mouse strain, as well as environmental insults, on the development of colonic inflammation in the absence of P-gp. Among the induction methods utilized, dextran sodium sulfate (DSS) disrupts the intestinal epithelium, while piroxicam is a nonsteroidal antiinflammatory (NSAID) drug that inhibits prostaglandin production and initiates colitis in IL10-deficient animals. Helicobacter bilis is a known mediator of bacterial-induced colitis. RESULTS: We demonstrate that crossing this mutation onto the C57BL/6 strain confers protection from spontaneous colitis. C57BL/6.mdr1a-deficient animals demonstrated increased histological inflammation, colonic shortening, fecal blood, and reduced body weight after 7 days of treatment with 2.25% DSS. C57BL/6.mdr1a-deficient mice treated with piroxicam or infected with H. bilis showed no weight loss, or alterations in colonic histology. CONCLUSIONS: These data indicate that the effects of P-gp deficiency are significantly modulated by background strain influences, but that the epithelium continues to have increased susceptibility to chemical injury in the C57BL/6 model.
BACKGROUND:P-glycoprotein (P-gp), the product of the multidrug resistance gene (MDR), is an ATP-dependent transmembrane pump, which is expressed in multiple cell lineages including epithelial and hematopoetic cells. The humanMDR gene is located on chromosome 7 (7q21.1), a susceptibility loci for inflammatory bowel disease (IBD). A significant number of IBDpatients carry mutations in this gene and P-gp-deficient FVB/Nmice develop a severe spontaneous colitis, characterized by impaired intestinal barrier function and immune reactivity to intestinal bacterial antigens. METHODS: In this work we explored the role of mouse strain, as well as environmental insults, on the development of colonic inflammation in the absence of P-gp. Among the induction methods utilized, dextran sodium sulfate (DSS) disrupts the intestinal epithelium, while piroxicam is a nonsteroidal antiinflammatory (NSAID) drug that inhibits prostaglandin production and initiates colitis in IL10-deficient animals. Helicobacter bilis is a known mediator of bacterial-induced colitis. RESULTS: We demonstrate that crossing this mutation onto the C57BL/6 strain confers protection from spontaneous colitis. C57BL/6.mdr1a-deficient animals demonstrated increased histological inflammation, colonic shortening, fecal blood, and reduced body weight after 7 days of treatment with 2.25% DSS. C57BL/6.mdr1a-deficient mice treated with piroxicam or infected with H. bilis showed no weight loss, or alterations in colonic histology. CONCLUSIONS: These data indicate that the effects of P-gp deficiency are significantly modulated by background strain influences, but that the epithelium continues to have increased susceptibility to chemical injury in the C57BL/6 model.
Authors: D C Haines; P L Gorelick; J K Battles; K M Pike; R J Anderson; J G Fox; N S Taylor; Z Shen; F E Dewhirst; M R Anver; J M Ward Journal: Vet Pathol Date: 1998-05 Impact factor: 2.221
Authors: J P Portanova; Y Zhang; G D Anderson; S D Hauser; J L Masferrer; K Seibert; S A Gregory; P C Isakson Journal: J Exp Med Date: 1996-09-01 Impact factor: 14.307
Authors: Elizabeth M Staley; Reed A Dimmitt; Trenton R Schoeb; Scott M Tanner; Robin G Lorenz Journal: J Pediatr Gastroenterol Nutr Date: 2011-12 Impact factor: 2.839
Authors: Scott T Espenschied; Mark R Cronan; Molly A Matty; Olaf Mueller; Matthew R Redinbo; David M Tobin; John F Rawls Journal: Proc Natl Acad Sci U S A Date: 2019-08-07 Impact factor: 11.205
Authors: Elizabeth M Staley; Vanisha R Yarbrough; Trenton R Schoeb; Joseph G Daft; Scott M Tanner; Dennis Steverson; Robin G Lorenz Journal: Radiat Res Date: 2012-07-10 Impact factor: 2.841
Authors: Reed A Dimmitt; Elizabeth M Staley; Gin Chuang; Scott M Tanner; Thomas D Soltau; Robin G Lorenz Journal: J Pediatr Gastroenterol Nutr Date: 2010-09 Impact factor: 2.839
Authors: Duy Huynh; Dilara Akçora; Jordane Malaterre; Chee Kai Chan; Xu-Ming Dai; Ivan Bertoncello; E Richard Stanley; Robert G Ramsay Journal: PLoS One Date: 2013-02-22 Impact factor: 3.240